Product Details:
Payment & Shipping Terms:
|
NAME: | Orlistat | Function: | Weight Loss |
---|---|---|---|
Style: | Powder | MOQ: | 10G |
Delivery: | 2-3 Working Days | Shipping: | POST,EMS,DHL,FEDEX |
Assay: | 99% Min | Shelf Life: | 2 Years |
Grade: | Top | ||
High Light: | weight stripping steroids,weight loss anabolic steroids |
Healthy Effective Weight Loss Drug Orlistat for Treating Obesity CAS 96829-58-2
Popular Steroid | ||
1 |
Testosterone Enanthate |
CAS: 315-37-7 |
2 |
Testosterone Acetate |
CAS: 1045-69-8 |
3 |
Testosterone Propionate |
CAS: 57-85-2 |
4 |
Testosterone Cypionate |
CAS: 58-20-8 |
5 |
Testosterone Phenylpropionate |
CAS: 1255-49-8 |
6 |
Testosterone Isocaproate |
CAS: 15262-86-9 |
7 |
Testosterone Decanoate |
CAS: 5721-91-5 |
8 |
Testosterone Undecanoate |
CAS: 5949-44-0 |
9 |
Sustanon 250 |
|
10 |
1-Testosterone Cypionate |
|
11 |
Turinabol |
CAS: 855-19-6 |
12 |
Oral Turinabol |
CAS: 2446-23-3 |
13 |
Stanolone |
CAS: 521-18-6 |
14 |
Nandrolone Decanoate (DECA) |
CAS: 360-70-3 |
15 |
Nandrolone Cypionate |
CAS: 601-63-8 |
16 |
Nandrolone Phenypropionate (NPP) |
CAS: 62-90-8 |
17 |
Boldenone Acetate |
CAS :2363-59-9 |
18 |
Boldenone Undecylenate (Equipoise) |
CAS: 13103-34-9 |
19 |
Drostanolone Propionate (Masteron) |
CAS: 521-12-0 |
20 |
Drostanolone Enanthate |
CAS: 472-61-1 |
21 |
Methenolone Acetate (Primobolan) |
CAS: 434-05-9 |
22 |
Methenolone Enanthate |
CAS: 303-42-4 |
23 |
Trenbolone Acetate |
CAS: 10161-34-9 |
24 |
Trenbolone Enanthate |
|
25 |
Trenbolone Hexahydrobenzyl Carbonate |
CAS: 23454-33-3 |
26 |
Epiandrosterone |
CAS: 481-29-8 |
|
||
27 |
Anavar |
CAS: 53-39-4 |
28 |
Anadrol |
CAS: 434-07-1 |
29 |
Winstrol |
CAS: 10418-03-8 |
30 |
Dianabol |
CAS: 72-63-9 |
31 |
Superdrol |
CAS: 3381-88-2 |
|
||
32 |
Tamoxifen Citrate (Nolvadex) |
CAS: 54965-24-1 |
33 |
Clomiphene Citrate (Clomid) |
CAS: 50-41-9 |
34 |
Toremifene Citrate (Fareston) |
CAS: 89778-27-8 |
35 |
Femara |
CAS: 112809-51-5 |
36 |
Aromasin |
CAS: 107868-30-4 |
37 |
Proviron |
CAS: 1424-00-6 |
38 |
Arimidex |
CAS: 120511-73-1 |
39 |
|
CAS: 566-48-3 |
40 |
Cabergoline (Caber) |
CAS: 81409-90-7 |
41 |
Finasteride |
CAS: 98319-26-7 |
42 |
Dutasteride |
CAS: 164656-23-9 |
|
||
43 |
Ostarine (MK-2866) |
CAS: 841205-47-8 |
44 |
Cardarine (GW-501516) |
CAS: 317318-70-0 |
45 |
Andarine (S4) |
CAS: 401900-40-1 |
46 |
Ligandrol (LGD-4033) |
CAS: 1165910-22-4 |
47 |
Ibutamoren (MK-677) |
CAS: 159752-10-0 |
48 |
RAD140 |
CAS: 118237-47-0 |
49 |
SR9009 |
CAS: 1379686-30-2 |
50 |
YK11 |
CAS: 431579-34-9 |
|
||
51 |
Avanafil |
CAS: 330784-47-9 |
52 |
Vardenafil |
CAS: 224785-91-5 |
53 |
|
CAS: 119356-77-3 |
54 |
Tadalafil |
CAS: 171596-29-5 |
|
|
|
56 |
Vardenafil Hydrochloride |
CAS: 431579-34-9 |
57 |
Hydrochloride |
CAS: 431579-34-9 |
58 |
Yohimbine Hydrochloride |
CAS: 65-19-0 |
|
||
59 |
T3 |
CAS: 55-06-1 |
60 |
T4 |
CAS: 51-48-9 |
61 |
Ethyl Oleate(EO) |
CAS: 111-62-6 |
62 |
Benzyl Alcohol (BA) |
CAS: 100-51-6 |
63 |
Benzyl Benzoate (BB) |
CAS: 120-51-4 |
64 |
Grape Seed Oil (GSO) |
CAS: 85594-37-2 |
65 |
2,4-Dinitrophenol (DNP) |
CAS: 51-28-5 |
66 |
1,3-Dimethylpentylamine (DMAA) |
CAS: 13803-74-2 |
67 |
4-Acetamidophenol (Paracetamol) |
CAS:103-90-2 |
68 |
Tauroursodeoxycholic Acid (TUDCA) |
CAS: 14605-22-2 |
69 |
Dextromethorphan Hydrobromide (DXM) |
CAS: 6700-34-1 |
|
|
|
|
Product Name |
Specification |
ACE 031 |
1 mg/vial, 10 vials/kit |
Follistatin 344 |
1 mg/vial, 10 vials/kit |
***************************** |
***************************** |
MGF |
2 mg/vial, 10 vials/kit |
PEG - MGF |
2 mg/vial, 10 vials/kit |
DSIP |
2 mg/vial, 10 vials/kit |
TB500 |
2 mg/5mg /vial, 10 vials/kit |
Oxytocin |
2 mg/vial, 10 vials/kit |
Hexarelin |
2 mg/vial, 10 vials/kit |
Triptorelin |
2 mg/vial, 10 vials/kit |
Ipamorelin |
2 mg/vial, 10 vials/kit |
Sermorelin |
2 mg/vial, 10 vials/kit |
Gonadorelin |
2 mg/vial, 10 vials/kit |
Tesamorelin |
2 mg/5mg /vial, 10 vials/kit |
BPC 157 |
2 mg/vial, 10 vials/kit |
AOD-9604 |
2 mg/vial, 10 vials/kit |
H 176-191 |
2 mg/vial, 10 vials/kit |
CJC-1295 |
2 mg/vial, 10 vials/kit |
CJC-1295 DAC |
2 mg/vial, 10 vials/kit |
***************************** |
***************************** |
GHRP-2 |
5 mg/vial, 10 vials/kit |
GHRP-6 |
5 mg/vial, 10 vials/kit |
Selank |
5 mg/vial, 10 vials/kit |
***************************** |
***************************** |
GHRP-2 |
5mg/10 mg/vial, 10 vials/kit |
GHRP-6 |
5mg/10 mg/vial, 10 vials/kit |
Epitalon |
10 mg/vial, 10 vials/kit |
PT-141 |
10 mg/vial, 10 vials/kit |
Gonadorelin |
10 mg/vial, 10 vials/kit |
Melanotan II |
10 mg/vial, 10 vials/kit |
Product introduction:
Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug.
The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggest that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug over the course of a year. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.
COA:
Product Name | Orlistat |
Synonyms | (S)-2-FORMYLAMINO-4-METHYL-PENTANOIC ACID (S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYL ESTER; RO-18-0647; (-)-TETRAHYDROLIPSTATIN; N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER; (-)-Tetrahydrolipstatin(EquivalentToOrlistat); Orlipastat; (1S)-1-{[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl N-formyl-D-leucinate; [(1S)-1-[[(2S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate |
Molecular Formula | C29H53NO5 |
Molecular Weight | 495.7348 |
InChI | InChI=1/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4) 21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25?,26-,27-/m0/s1 |
CAS Registry Number | 96829-58-2 |
Density | 0.976g/cm3 |
Boiling point | 615.9°C at 760 mmHg |
Refractive index | 1.469 |
Flash point | 326.3°C |
Vapour Pressure | 4.23E-15mmHg at 25°C |
Assay | 99% |
Appearance | White or white powder |
Orlistat Usage:
1. Orlistat is a drug designed for obesity treatment, is internationally recognized as a new type of lipid-lowering drugs to lose weight.
2. it primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet
3. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini.However.
4. Due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug.
Our Packing: